Boston Medical Center (BMC) Grayken Center for Addiction Training and Technical Assistance (TTA)

A Resource for Healthcare and Social Services Professionals

Essentials of Office-Based Addiction Treatment - Health Care for the Homeless

July 16, 2019
12:00 pm–4:00 pm ET

PLEASE NOTE: This event is open to nurses and other clinical staff of Pine Street Inn only. This 4-hour course prepares nurses and other medical staff to manage office-based addiction treatment with buprenorphine and naltrexone.

Register now


Pine Street Inn
444 Harrison Avenue
6th Floor
Boston, MA


PLEASE NOTE: This event is open to nurses and other clinical staff of Pine Street Inn only.

This course will prepare nurses and other key members of the multidisciplinary care team to deliver medication for addiction treatment (MAT), such as buprenorphine and naltrexone, using a chronic care management model, with a specific focus on caring for homeless patients. Topics covered will include the science of addiction as a brain disorder, the pharmacotherapy of medications used to treat opioid and alcohol use disorders (current standard of care), and practical tools for implementing these treatment modalities into an office-based setting and for supporting nurses and other clinicians who are part of the care team. Attendees will learn to screen patients for substance use disorders, initiate medication, and provide ongoing care and counseling.

Check-in for the course will be from 11:30 am to 12:00 pm and the training will run from 12:00 pm to 4:00 pm.

A light lunch will be provided. If you have dietary restrictions please feel free to let us know and we will do our best to accommodate them. 

We will be offering 4.0 CE units for nursing.

This is an in-person training. There will not be an option to attend via webinar.

Intended audience

Nurses and other clinical staff providing treatment for substance use disorders in an office-based setting at Pine Street Inn.


The learner will: Define opioid use disorder; Explain methods used to evaluate patients for treatment with buprenorphine and injectable naltrexone; Identify the clinically relevant pharmacological characteristics of buprenorphine and buprenorphine/naloxone; and Outline tools for monitoring and supporting patients engaged in Medication for Addiction Treatment (MAT).

Sponsored by

Boston Medical Center Grayken Center for Addiction, Department of Public Health, Bureau of Addiction Services

Accreditation information

Boston Medical Center grants 4 hours to all RNS who attend, complete and evaluation and complete the post test. Boston Medical Center is an approved provider of continuing nursing education by American Nurses Association, Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. 

Register now

Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.

Funding for Grayken Center for Addiction TTA is provided by:

Massachusetts Department of Public Health Bureau of Substance Abuse Services (BSAS)
GE Foundation
Opioid Response Network

The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.

© 2024 Boston Medical Center. All rights reserved. Site by Root802.